Atrium Advanta V12 Covered Stent System (OUS only). Product Code/Part Number: 85320 85321 85322 85323 85324 85325 85326

FDA device recall Z-1076-2022 · posted 2022-05-18 · Open, Classified

Recall details

Recalling firm

Atrium Medical Corporation

Reason for recall

Firm has observed increased rate of customer complaints related to separation of the balloon or catheter hub from the delivery catheter during delivery system withdrawal causing procedural delay and possible administration of additional anesthesia and contrast which may impact patients' renal function. Potential harms include occlusion or embolism and associated response, with specific outcomes such as amputation, embolism, loss of organ function, organ infarction, or tissue infarction. ***Updated June 2023*** Additional surgical stress caused by prolonged interventional surgery has the potential to lead to myocardial infarction or death.

Action taken

Atrium/Getinge issued Urgent Field Safety Notification to Hospitals (OUS) via on 3/03/22 via email. Letter states reason for recall, health risk and action to take: The company is updating the Advanta V12 Covered Stent System Instructions for Use (IFU). REVISED: Deflation and Withdrawal Instructions: Deflate balloon by pulling vacuum on the inflation device to its maximum volume and allow sufficient time for full deflation. IMPORTANT: Visually verify full deflation of the balloon via fluoroscopy before attempting to withdraw the delivery system. You may continue to use the Advanta V12 Covered Stent Systems, with the consideration of this revised information, which is included on the following page. No Devices Need to Be Returned. If you have any questions, please contact your local Getinge representative. ***UPDATE APRIL 2022*** On April 22, 2022, the firm expanded its recall to include the iCast Covered Stent System. If the device is inflated/deflated using higher concentrations of contrast media or other viscous fluid, as may occur in off-label endovascular procedures, a balloon may take longer to deflate than prescribed in the iCast IFU. Letters were issued to consignees via FedEx with delivery receipt. Customers were informed they may continue to use the iCast covered stent with the consideration of the Deflation and Withdrawal Instructions when used for endovascular procedures. ***UPDATE JUNE 2023*** On June 13, 2023, the firm sent an updated letter to customers to reflect an updated Risk to Health due to new complaint data. ALL LOTS of product, including lots manufactured after May 2020, are affected.

Root cause

Device Design

Status

Open, Classified

Product code

JCT

Quantity affected

105,968 units

Distribution

Foreign: Australia Austria Bahrain Belgium Bosnia-Herzegovina Brazil Bulgaria Canada Chile Colombia Costa Rica Cyprus Czech Republic Denmark Ecuador Egypt El Salvador Estonia Finland France Germany Gr

Date initiated

2022-03-03

Date posted

2022-05-18

Location

Merrimack, NH